» Articles » PMID: 22007145

Serum Antibodies Protect Against Intraperitoneal Challenge with Enterotoxigenic Escherichia Coli

Overview
Specialty Biology
Date 2011 Oct 19
PMID 22007145
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

To assess whether anticolonization factor antigen I (CFA/I) fimbriae antibodies (Abs) from enterotoxigenic Escherichia coli (ETEC) can protect against various routes of challenge, BALB/c mice were immunized with a live attenuated Salmonella vaccine vector expressing CFA/I fimbriae. Vaccinated mice elicited elevated systemic IgG and mucosal IgA Abs, unlike mice immunized with the empty Salmonella vector. Mice were challenged with wild-type ETEC by the oral, intranasal (i.n.), and intraperitoneal (i.p.) routes. Naïve mice did not succumb to oral challenge, but did to i.n. challenge, as did immunized mice; however, vaccinated mice were protected against i.p. ETEC challenge. Two intramuscular (i.m.) immunizations with CFA/I fimbriae without adjuvant conferred 100% protection against i.p. ETEC challenge, while a single 30 μg dose conferred 88% protection. Bactericidal assays showed that ETEC is highly sensitive to anti-CFA/I sera. These results suggest that parenteral immunization with purified CFA/I fimbriae can induce protective Abs and may represent an alternative method to elicit protective Abs for passive immunity to ETEC.

Citing Articles

A low-cost recombinant glycoconjugate vaccine confers immunogenicity and protection against enterotoxigenic infections in mice.

Williams A, Warfel K, Desai P, Li J, Lee J, Wong D Front Mol Biosci. 2023; 10:1085887.

PMID: 36936989 PMC: 10018396. DOI: 10.3389/fmolb.2023.1085887.


Protective efficacy of a novel multivalent vaccine in the prevention of diarrhea induced by enterotoxigenic in a murine model.

Zhao H, Xu Y, Li G, Liu X, Li X, Wang L J Vet Sci. 2021; 23(1):e7.

PMID: 34841745 PMC: 8799940. DOI: 10.4142/jvs.21068.


Viral and bacterial infections associated with camel (Camelus dromedarius) calf diarrhea in North Province, Saudi Arabia.

Al-Ruwaili M, Khalil O, Selim S Saudi J Biol Sci. 2013; 19(1):35-41.

PMID: 23961160 PMC: 3730540. DOI: 10.1016/j.sjbs.2011.10.001.


Attenuating gene expression (AGE) for vaccine development.

Pascual D, Suo Z, Cao L, Avci R, Yang X Virulence. 2013; 4(5):384-90.

PMID: 23652809 PMC: 3714130. DOI: 10.4161/viru.24886.


Adhesion protein ApfA of Actinobacillus pleuropneumoniae is required for pathogenesis and is a potential target for vaccine development.

Zhou Y, Li L, Chen Z, Yuan H, Chen H, Zhou R Clin Vaccine Immunol. 2012; 20(2):287-94.

PMID: 23269417 PMC: 3571269. DOI: 10.1128/CVI.00616-12.


References
1.
Eriksson K, Holmgren J . Recent advances in mucosal vaccines and adjuvants. Curr Opin Immunol. 2002; 14(5):666-72. DOI: 10.1016/s0952-7915(02)00384-9. View

2.
Jones G, Rutter J . Role of the K88 antigen in the pathogenesis of neonatal diarrhea caused by Escherichia coli in piglets. Infect Immun. 1972; 6(6):918-27. PMC: 419313. DOI: 10.1128/iai.6.6.918-927.1972. View

3.
North M, Newton C, Wright D, Webster A . Bactericidal activity of serum for Klebsiella rhinoscleromatis: studies on serum from a patient with rhinoscleroma and sera deficient in antibody or complement. J Med Microbiol. 1982; 15(2):267-72. DOI: 10.1099/00222615-15-2-267. View

4.
Snodgrass D, NAGY L, Sherwood D, Campbell I . Passive immunity in calf diarrhea: vaccination with K99 antigen of enterotoxigenic Escherichia coli and rotavirus. Infect Immun. 1982; 37(2):586-91. PMC: 347573. DOI: 10.1128/iai.37.2.586-591.1982. View

5.
Barry E, Altboum Z, Losonsky G, Levine M . Immune responses elicited against multiple enterotoxigenic Escherichia coli fimbriae and mutant LT expressed in attenuated Shigella vaccine strains. Vaccine. 2003; 21(5-6):333-40. DOI: 10.1016/s0264-410x(02)00611-4. View